Dihydro Tofacitinib Citrate Impurity

Status: In-stock

Dihydro Tofacitinib Citrate Impurity (CAS No: N/A) Or 3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)as a targeted immunomodulator(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate, Dihydro Tofacitinib Citrate is an impurity of Tofacitinib, tofacitinib inhibits JAK1, JAK2, which is investigated as a targeted immunomodulator.

Request quotation

Additional information on Dihydro Tofacitinib Citrate Impurity

Catalogue No. VE008139
Molecular Formula C16H22N6O . C6H8O7
Molecular Weight 506.51 g/mol
Parent drug Tofacitinib
IUPAC Name 3-((3R, 4R)-3-((6, 7-dihydro-5H-pyrrolo[2, 3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1, 2, 3-tricarboxylate
Synonyms N/A
References Sci-Hub, Evaluation of the effect of fluconazole and ketoconazole on the pharmacokinetics of tofacitinib in healthy adult subjects, 10.1002/cpdd.71. (2014). Retrieved January 29, 2022, from Sci-hub.ee website: https://sci-hub.ee/https://doi.org/10.1002/cpdd.71 ?
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

Dihydro Tofacitinib Citrate Impurity

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.